Published in Heart Fail Rev on September 01, 2010
Heart failure in elderly patients: distinctive features and unresolved issues. Eur J Heart Fail (2013) 1.66
AICAR-dependent AMPK activation improves scar formation in the aged heart in a murine model of reperfused myocardial infarction. J Mol Cell Cardiol (2013) 0.86
Role of ACE2 in diastolic and systolic heart failure. Heart Fail Rev (2012) 0.85
Atrial fibrillation and heart failure in the elderly. Heart Fail Rev (2012) 0.83
Global myocardial strain assessment by different imaging modalities to predict outcomes after ST-elevation myocardial infarction: A systematic review. World J Cardiol (2015) 0.80
Prevention of heart failure in the elderly: when, where and how to begin? Heart Fail Rev (2012) 0.79
Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly. Clin Interv Aging (2010) 0.77
The continuing saga of aging and heart failure. Heart Fail Rev (2012) 0.75
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation (1990) 9.74
Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation (2003) 7.40
The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation (1977) 5.67
Epidemiology, aetiology, and prognosis of heart failure. Heart (2000) 4.42
The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA (1992) 4.28
Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA (2001) 4.28
Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA (2009) 4.24
A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol (1999) 4.00
Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke council. Circulation (2006) 3.93
Acute myocardial infarction. Lancet (2003) 3.59
Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J (2001) 3.49
Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation (2002) 3.47
Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J (2006) 3.46
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation (1995) 3.38
Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J (2005) 2.94
Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation (2003) 2.87
Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol (2009) 2.82
Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol (2003) 2.46
Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med (1997) 2.30
Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction. Eur Heart J (2005) 2.30
Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction: the Worcester Heart Attack study. Arch Intern Med (2000) 2.16
Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol (2002) 2.13
Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? Am J Med (1992) 2.08
Healing after myocardial infarction. Cardiovasc Res (2005) 2.05
Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative. J Am Coll Cardiol (2007) 2.03
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA (1996) 1.99
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol (1996) 1.91
Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol (2008) 1.90
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation (1996) 1.87
Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med (1993) 1.81
The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol (2001) 1.60
On the rise: The current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol (2003) 1.54
Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation (2000) 1.54
Heart failure after myocardial infarction: prevalence of preserved left ventricular systolic function in the community. Am Heart J (2003) 1.53
Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol (1998) 1.51
Functional impact of remodeling during healing after non-Q wave versus Q wave anterior myocardial infarction in the dog. J Am Coll Cardiol (1992) 1.44
Aging mouse hearts are refractory to infarct size reduction with post-conditioning. J Am Coll Cardiol (2008) 1.43
The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure. Can J Cardiol (2001) 1.11
Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev (2010) 1.10
Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J (1994) 1.05
Diastolic heart failure in the elderly: underlying mechanisms and clinical relevance. Int J Cardiol (2007) 1.04
Epidemiology, clinical features, and prognosis of acute myocardial infarction in the elderly. Am J Geriatr Cardiol (2006) 1.00
Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J (2003) 0.97
Outcomes and prognostic factors of systolic as compared with diastolic heart failure in urban America. Congest Heart Fail (2005) 0.96
Prevention of ventricular remodelling post myocardial infarction: timing and duration of therapy. Can J Cardiol (1993) 0.92
Decreasing polypharmacy in clients most at risk. AACN Clin Issues (1997) 0.91
Aging and remodeling during healing of the wounded heart: current therapies and novel drug targets. Curr Drug Targets (2008) 0.90
Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction. Am J Cardiol (2009) 0.87
Acute myocardial infarction in the elderly--the differences compared with the young. Singapore Med J (2003) 0.83
Aging and defective healing, adverse remodeling, and blunted post-conditioning in the reperfused wounded heart. J Am Coll Cardiol (2008) 0.82
Identification of patients prone to infarct expansion by the degree of regional shape distortion on an early two-dimensional echocardiogram after myocardial infarction. Clin Cardiol (1990) 0.81
Polypharmacy and elderly patients. AORN J (1999) 0.80
Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study. Eur Heart J (2009) 0.79
Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction. Circulation (2007) 0.78
Impact of increased infarct transmurality on remodeling and function during healing after anterior myocardial infarction in the dog. Can J Physiol Pharmacol (1992) 0.77
Heart failure in the elderly: advances and challenges. Expert Rev Cardiovasc Ther (2010) 0.77
Ventricular free wall rupture in acute myocardial infarction. J Cardiovasc Pharmacol Ther (2001) 0.76
Risk of stroke after myocardial infarction. N Engl J Med (1997) 0.75
Women and men with unstable angina and/or non-ST-elevation myocardial infarction. Wien Klin Wochenschr (2006) 0.75
Increased burden of coronary artery disease in South-Asians living in North America. Need for an aggressive management algorithm. Atherosclerosis (2008) 1.43
Apoptosis and oxidants in the heart. J Lab Clin Med (2003) 1.43
Large pulmonary artery aneurysm associated with Marfan syndrome. Int J Angiol (2010) 0.92
Detection of regional changes in protein levels in the in vivo canine model of acute heart failure following ischemia-reperfusion injury: functional proteomics studies. Proteomics (2004) 0.87
AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts. Am J Physiol Heart Circ Physiol (2002) 0.84
Matrix metalloproteinases as markers of adverse remodeling after myocardial infarction. J Card Fail (2006) 0.83
Atrial fibrillation and heart failure in the elderly. Heart Fail Rev (2012) 0.83
Mechanical circulatory support for elderly heart failure patients. Heart Fail Rev (2012) 0.83
The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly. Heart Fail Rev (2012) 0.82
Systolic heart failure in the elderly: optimizing medical management. Heart Fail Rev (2012) 0.82
Aging and defective healing, adverse remodeling, and blunted post-conditioning in the reperfused wounded heart. J Am Coll Cardiol (2008) 0.82
Improved balance between TIMP-3 and MMP-9 after regional myocardial ischemia-reperfusion during AT1 receptor blockade. J Card Fail (2004) 0.81
Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinases during myocardial ischemia-reperfusion. Mol Cell Biochem (2004) 0.79
Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion in isolated working rat hearts. J Cardiovasc Pharmacol Ther (2003) 0.78
Preventing adverse remodeling and rupture during healing after myocardial infarction in mice and humans. Circulation (2010) 0.78
Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction. Circulation (2007) 0.78
Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction. Mol Cell Biochem (2013) 0.77
The relationship between markers of extracellular cardiac matrix turnover: infarct healing and left ventricular remodelling following primary PCI in patients with first-time STEMI. Eur Heart J (2013) 0.76
Valsartan reverses post-translational modifications of the delta-subunit of ATP synthase during in vivo canine reperfused myocardial infarction. Proteomics (2007) 0.76
Comparison of vasopeptidase inhibitor omapatrilat and angiotensin receptor blocker candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction. Mol Cell Biochem (2008) 0.76
Ventricular unloading, tissue angiotensin II, matrix modulation, and function during left ventricular assist device support. J Am Coll Cardiol (2007) 0.76
Fine-tuning blood pressure control to minimize cardiovascular risk. Prev Cardiol (2007) 0.75
Monocytosis and adverse left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol (2002) 0.75
Selective type 1 angiotensin II receptor blockade attenuates oxidative stress and regulates angiotensin II receptors in the canine failing heart. Mol Cell Biochem (2008) 0.75
Increased AT(2)R protein expression but not increased apoptosis during cardioprotection induced by AT(1)R blockade. Can J Cardiol (2002) 0.75
Optimizing pharmacotherapy for limiting cardiovascular remodeling a matter of timing therapy to match biology. J Am Coll Cardiol (2011) 0.75
Assessment of diastolic dysfunction after acute myocardial infarction using Doppler echocardiography. Can J Cardiol (2002) 0.75
Increased AT2R protein expression but not increased apoptosis during cardioprotection induced by AT1R blockade. Can J Cardiol (2002) 0.75
Heart failure is an especially important problem in the elderly. Heart Fail Rev (2010) 0.75
Nuclear-mitochondrial cross-talk in global myocardial ischemia. A time-course analysis. Mol Cell Biochem (2012) 0.75